sigmoid colon. Frozen section histological examination did not identify the nature of the mass, which was resected en bloc with ileocolic anastomosis. On histological examination the polypoid lesion removed from the ascending colon contained adenomatous glands with low grade dysplasia admixed with numerous foci of endometriosis resulting in marked expansion of the polypoid fronds ( Figure 2 a and b) . Immunohistochemical staining clearly differentiated between colonic glands (cytokeratin 20 positive, cytokeratin 7 negative) and endometrial glands (cytokeratin 7 positive, cytokeratin 20 negative, Figure 2 b and c). Sections from the retroperitoneal mass showed endometriosis. The patient has had no further colonic bleeding during 25 months' follow-up.
COMMENT
Colonic endometriosis can mimic colorectal cancer by producing an invasive abdominal mass associated with abdominal pain, bleeding 1 or an ulcer 2,3 , but`adenomatous' change within colonic mucosa does not seem to have been reported previously. The present case suggests that colonic mucosal endometriosis can produce reactive changes in colonic glands, with cellular atypia and glandular hyperplasia mimicking dysplasia, thus making the lesions harder to discriminate from a neoplastic adenoma. It is possible that the`adenomatous' lesion in this case resulted from invasion of a pre-existing neoplastic adenoma by endometriosis, but this is unlikely in view of the patient's young age and the absence of a history of colonic adenomas in the patient or her family. Although the colonic lesion in the present case was more fronded than a typical neoplastic adenoma, it would be dif®cult to use this appearance at colonoscopy to differentiate between the two conditions, since surface irregularity is also associated with malignant transformation within neoplastic adenomas.
Although endometriosis can mimic all stages of colorectal neoplasia, discrimination between colonic glands and endometrial glands is possible with cytokeratin immunostaining. strong family history of type 1 diabetes (including a brother and a ®rst cousin) and her mother had checked her blood glucose with a meter. The reading was 13.4 mmol/L 2 hours after food. On examination her temperature was 37.4 8C and she had mild tender submandibular lymphadenopathy and tonsillar erythema. She was slim, with a body mass index of 23. She had never experienced any osmotic or other symptoms suggestive of diabetes. In the fasting state, urine was negative for glucose and ketones and plasma glucose was 5.9 mmol/L. Further blood tests showed a normal full blood count, including differential, and normal renal, liver and thyroid function. A monospot test was positive, and infectious mononucleosis was thought the likely cause of her symptoms. She was advised to rest, and to test her blood sugar occasionally, fasting and 2 hours after meals. Postprandial hyperglycaemia continued with blood sugars on her meter ranging from 9 to 14 mmol/L. Urine remained negative for ketones and glucose. An oral glucose tolerance test (OGTT) pointed to diabetes and she was referred to the hospital diabetes clinic. Blood sugars continued at 4±7 mmol/L before meals and up to 14 mmol/L postprandially. She was now symptom-free, having recovered from her bout of infectious mononucleosis. There was no evidence of diabetic complications. Glycated haemoglobin indicated good control at 6.7%. Glutamic acid decarboxylase-65 antibody (GAD65) and islet cell antibody (ICA) markers for type 1 diabetes were strongly positive. An OGTT three months after the ®rst showed no change (Table 1) . Six months after diagnosis she is taking repaglinide 0.5 mg with meals and has good postprandial glycaemic control. She has been offered lowdose preprandial insulin but prefers to use oral medication for as long as possible.
Subclinical type 1 diabetes

COMMENT
The Diabetes Prevention Trial Investigators have described a group of patients who are diagnosed with type 1 diabetes on the basis of OGTT alone 1 . The study involved screening all ICA-positive relatives of a cohort of type 1 diabetic patients with OGTT to determine glycaemic status and intravenous GTT to determine ®rst-phase insulin response. Of 585 relatives screened, 73% had normal glucose tolerance, 14.9% had impaired glucose tolerance and 10.4% had diabetes. Amongst the diabetic cohort, diabetes was diagnosed generally on the basis of postprandial hyperglycaemia rather than fasting hyperglycaemia. In addition, these patients had an impaired ®rst-phase insulin response to a glucose load and high-risk diabetes HLA haplotypes were common in this group. All were symptomfree and the age range was 3±45 years. The fact that they are young and ICA-positive, have a ®rst-degree relative with type 1 diabetes, and possess high-risk HLA haplotypes makes it very likely they have true type 1 diabetes and will eventually develop symptomatic disease requiring insulin.
This newly described subset gives some clue as to the natural history of type 1 diabetes before it becomes clinically apparent. The impaired ®rst-phase response to a glucose load suggests that the earliest manifestation of beta cell failure is loss of acute insulin response to a glucose load, leading to postprandial hyperglycaemia. The viral illness in our patient may or may not have in¯uenced her glycaemic status, but we note that glucose tolerance was unaltered after recovery. An unanswered question is whether`resting' the beta-cells with low-dose insulin or immunomodulatory therapies such as cyclosporin will prevent or delay progression to full-blown diabetes 2 In Parkinson's disease (PD) imaging of the brain is seldom cost-effective since the chance of detecting relevant structural abnormality as a cause of the symptoms is very low. However, brain imaging can provide diagnostic clues in young patients with atypical parkinsonian features. 
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